Bortezomib on a Modified Augmented BFM Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy)

This trial compares how well combination chemotherapy works when given with or without bortezomib in treating patients

November 10, 2017